UNITED THERAPEUTICS Corp - COM (UTHR)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
45.8M
Holdings value Q2 2024
$14.6B
Value change Q2 2024
+$487M
Grand Portfolio weight change Q2 2024
+0.001%
Number of holders
550
Number of buys Q2 2024
90
Number of sells Q2 2024
-47
Average buys Q2 2024 %
+0.004%
Average sells Q2 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 1.93M $691M -$27.4M $358.35 156
2024 Q2 45.8M $14.6B +$487M $318.55 558
2024 Q1 44.6M $10.3B +$32.7M $229.72 514
2023 Q4 44.1M $9.7B +$136M $219.89 521
2023 Q3 43.5M $9.83B -$237M $225.87 501
2023 Q2 44.5M $9.82B -$52.1M $220.75 465
2023 Q1 44.6M $10B -$17.7M $223.96 492
2022 Q4 44.3M $12.3B +$57.3M $278.09 500
2022 Q3 44.1M $9.23B +$59.4M $209.38 446
2022 Q2 43.6M $10.3B +$129M $235.64 459
2022 Q1 43.6M $7.81B +$133M $179.41 413
2021 Q4 42.7M $9.22B -$262M $216.08 409
2021 Q3 43.7M $8.07B +$111M $184.58 411
2021 Q2 43M $7.72B +$7.16M $179.41 396
2021 Q1 43M $7.2B +$26.8M $167.27 385
2020 Q4 43M $6.53B +$196M $151.79 350
2020 Q3 41.9M $4.23B -$29.1M $101.00 322
2020 Q2 42.1M $5.09B -$63.2M $121.00 338
2020 Q1 42.9M $4.07B +$176M $94.83 293
2019 Q4 41.2M $3.63B -$10.3M $88.08 310
2019 Q3 41.4M $3.3B -$42.8M $79.75 293
2019 Q2 41.9M $3.27B -$120M $78.06 311
2019 Q1 42.8M $5.02B -$2.43M $117.37 367
2018 Q4 42.8M $4.64B -$45M $108.90 350
2018 Q3 42.9M $5.48B +$109M $127.88 361
2018 Q2 42.1M $4.76B -$157M $113.15 364
2018 Q1 43.4M $4.87B -$811K $112.36 366
2017 Q4 43.8M $6.47B +$1.67M $147.95 396
2017 Q3 43.7M $5.12B -$333M $117.19 365
2017 Q2 46.3M $6.01B -$200M $129.73 369
2017 Q1 47.7M $6.46B +$601M $135.38 404
2016 Q4 47.4M $6.8B -$175M $143.43 396
2016 Q3 48.6M $5.73B -$103M $118.08 384
2016 Q2 49.5M $5.24B -$108M $105.92 376
2016 Q1 50.6M $5.64B -$83.2M $111.43 391
2015 Q4 50.8M $7.96B -$13.6M $156.61 383
2015 Q3 50.6M $6.64B -$65.8M $131.24 365
2015 Q2 50.9M $8.86B -$252M $173.95 381
2015 Q1 52.4M $9.03B +$261M $172.43 367
2014 Q4 51M $6.61B -$258M $129.49 332
2014 Q3 52.8M $6.8B +$111M $128.65 320
2014 Q2 52.2M $4.62B -$149M $88.49 303
2014 Q1 53.7M $5.05B -$117M $94.03 304